BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 27179449)

  • 1. New trans dichloro (triphenylphosphine)platinum(II) complexes containing N-(butyl),N-(arylmethyl)amino ligands: Synthesis, cytotoxicity and mechanism of action.
    Dalla Via L; García-Argáez AN; Agostinelli E; Belli Dell'Amico D; Labella L; Samaritani S
    Bioorg Med Chem; 2016 Jul; 24(13):2929-2937. PubMed ID: 27179449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New trans-platinum drugs with phosphines and amines as carrier ligands induce apoptosis in tumor cells resistant to cisplatin.
    Ramos-Lima FJ; Quiroga AG; García-Serrelde B; Blanco F; Carnero A; Navarro-Ranninger C
    J Med Chem; 2007 May; 50(9):2194-9. PubMed ID: 17407274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and in vitro cytotoxicity of novel hydrophilic chiral 2-alkoxy-1,4-butanediamine platinum (II) complexes.
    Zhu H; Cui K; Wang L; Gou S
    Bioorg Med Chem Lett; 2005 Nov; 15(22):4936-43. PubMed ID: 16169720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the trans geometry in platinum antitumor complexes: a survey of the cytotoxicity of trans complexes containing planar ligands in murine L1210 and human tumor panels and studies on their mechanism of action.
    Farrell N; Kelland LR; Roberts JD; Van Beusichem M
    Cancer Res; 1992 Sep; 52(18):5065-72. PubMed ID: 1516063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cationic nonsymmetric transplatinum complexes with piperidinopiperidine ligands. Preparation, characterization, in vitro cytotoxicity, in vivo toxicity, and anticancer efficacy studies.
    Najajreh Y; Khazanov E; Jawbry S; Ardeli-Tzaraf Y; Perez JM; Kasparkova J; Brabec V; Barenholz Y; Gibson D
    J Med Chem; 2006 Jul; 49(15):4665-73. PubMed ID: 16854072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, characterization, and biological activity of platinum II, III, and IV pivaloamidine complexes.
    Sinisi M; Gandin V; Saltarella T; Intini FP; Pacifico C; Marzano C; Natile G
    J Biol Inorg Chem; 2014 Oct; 19(7):1081-97. PubMed ID: 24850131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, characterization, and biological evaluation of new tetrazole-based platinum(II) and palladium(II) chlorido complexes--potent cisplatin analogues and their trans isomers.
    Serebryanskaya TV; Yung T; Bogdanov AA; Shchebet A; Johnsen SA; Lyakhov AS; Ivashkevich LS; Ibrahimava ZA; Garbuzenco TS; Kolesnikova TS; Melnova NI; Gaponik PN; Ivashkevich OA
    J Inorg Biochem; 2013 Mar; 120():44-53. PubMed ID: 23305964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cisplatinum and transplatinum complexes with benzyliminoether ligands; synthesis, characterization, structure-activity relationships, and in vitro and in vivo antitumor efficacy.
    Sbovata SM; Bettio F; Mozzon M; Bertani R; Venzo A; Benetollo F; Michelin RA; Gandin V; Marzano C
    J Med Chem; 2007 Sep; 50(19):4775-84. PubMed ID: 17713897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and in vitro antiproliferative activity of platinum(II) complexes with N-monoalkyl 1R,2R-diaminocyclohexane as ligands.
    Sun Y; Liu F; Gou S; Cheng L; Fang L; Yin R
    Eur J Med Chem; 2012 Sep; 55():297-306. PubMed ID: 22867527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxicity profile of novel sterically hindered platinum(II) complexes with (1R,2R)-N(1),N(2)-dibutyl-1,2-diaminocyclohexane.
    Zhang H; Gou S; Zhao J; Chen F; Xu G; Liu X
    Eur J Med Chem; 2015; 96():187-95. PubMed ID: 25874342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, characterization and cytotoxic activity of novel platinum(II) iodido complexes.
    Savić A; Filipović L; Aranđelović S; Dojčinović B; Radulović S; Sabo TJ; Grgurić-Šipka S
    Eur J Med Chem; 2014 Jul; 82():372-84. PubMed ID: 24927057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and characterization of platinum(II) oxadiazoline complexes and their in vitro antitumor activity in platinum-sensitive and -resistant cancer cell lines.
    Coley HM; Sarju J; Wagner G
    J Med Chem; 2008 Jan; 51(1):135-41. PubMed ID: 18072719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platinum(II/IV) complexes containing ethylenediamine-N,N'-di-2/3-propionate ester ligands induced caspase-dependent apoptosis in cisplatin-resistant colon cancer cells.
    Kaluđerović GN; Mijatović SA; Zmejkovski BB; Bulatović MZ; Gómez-Ruiz S; Mojić MK; Steinborn D; Miljković DM; Schmidt H; Stošić-Grujičić SD; Sabo TJ; Maksimović-Ivanić DD
    Metallomics; 2012 Aug; 4(9):979-87. PubMed ID: 22820831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationship of new trans-platinum(II) and (IV) complexes with cyclohexylamine. Interference with cell cycle progression and induction of cell death.
    González-Vadillo AM; Alvarez-Valdés A; Moneo V; Blanco F; Díaz RG; Carnero A; Navarro-Ranninger C
    J Inorg Biochem; 2007 Apr; 101(4):551-8. PubMed ID: 17257684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel methylene modified cyclohexyl ethylenediamine-N,N'-diacetate ligands and their platinum(IV) complexes. Influence on biological activity.
    Mihajlović LE; Savić A; Poljarević J; Vučković I; Mojić M; Bulatović M; Maksimović-Ivanić D; Mijatović S; Kaluđerović GN; Stošić-Grujičić S; Miljković Đ; Grgurić-Šipka S; Sabo TJ
    J Inorg Biochem; 2012 Apr; 109():40-8. PubMed ID: 22369771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic malonate platinum(II) complexes with 1,2,4-triazolo[1,5-a]pyrimidine derivatives: structural characterization and mechanism of the suppression of tumor cell growth.
    Łakomska I; Hoffmann K; Wojtczak A; Sitkowski J; Maj E; Wietrzyk J
    J Inorg Biochem; 2014 Dec; 141():188-197. PubMed ID: 25277461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trans-platinum(II) complexes with cyclohexylamine as expectator ligand induce necrosis in tumour cells by inhibiting DNA synthesis and RNA transcription.
    Cepero V; García-Serrelde B; Moneo V; Blanco F; González-Vadillo AM; Alvarez-Valdés A; Navarro-Ranninger C; Carnero A
    Clin Transl Oncol; 2007 Aug; 9(8):521-30. PubMed ID: 17720655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of some platinum(II/IV) complexes with O,O-n-butyl-and O,O-n-pentyl-ethylenediamine-N,N'-di-3-propanoate and halogeno ligands against HeLa and K562 cell lines and human PBMC.
    Kaluderović GN; Dinović VM; Juranić ZD; Stanojković TP; Sabo TJ
    J Inorg Biochem; 2005 Feb; 99(2):488-96. PubMed ID: 15621281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, characterization and cytotoxicity evaluation of some new platinum(II) complexes of tetrazolo[1,5-a]quinolines.
    Bekhit AA; El-Sayed OA; Al-Allaf TA; Aboul-Enein HY; Kunhi M; Pulicat SM; Al-Hussain K; Al-Khodairy F; Arif J
    Eur J Med Chem; 2004 Jun; 39(6):499-505. PubMed ID: 15183908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor trans-N-heterocyclic carbene-amine-Pt(II) complexes: synthesis of dinuclear species and exploratory investigations of DNA binding and cytotoxicity mechanisms.
    Chtchigrovsky M; Eloy L; Jullien H; Saker L; Ségal-Bendirdjian E; Poupon J; Bombard S; Cresteil T; Retailleau P; Marinetti A
    J Med Chem; 2013 Mar; 56(5):2074-86. PubMed ID: 23421599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.